Eli Lilly sued by Texas AG, company accused of ‘bribing providers’

Texas Attorney General Ken Paxton sued Eli Lilly (LLY) for “bribing and illegally inducing medical providers to prescribe its most profitable drugs,” including the high-demand GLP-1 medications Mounjaro and Zepbound that are used for weight loss and diabetes treatment, the AG announced. “Big Pharma compromised medical decision-making by engaging in an illegal kickback scheme. Eli Lilly fraudulently sought to maximize profits at taxpayer expense and put corporate greed over people’s health. I will not stand by while corporations unlawfully manipulate our healthcare system to line their own pockets,” said Attorney General Paxton.